Shah Rachit, Maize Kimberly M, Zhou Xin, Finzel Barry C, Wagner Carston R
Department of Medicinal Chemistry University of Minnesota , Minneapolis, Minnesota 55455, United States.
Biochemistry. 2017 Jul 18;56(28):3559-3570. doi: 10.1021/acs.biochem.7b00148. Epub 2017 Jul 10.
Human histidine triad nucleotide binding protein 1 (hHint1) is classified as an efficient nucleoside phosphoramidase and acyl-adenosine monophosphate hydrolase. Human Hint1 has been shown to be essential for the metabolic activation of nucleotide antiviral pronucleotides (i.e., proTides), such as the FDA approved hepatitis C drug, sofosbuvir. The active site of hHint1 comprises an ensemble of strictly conserved histidines, including nucleophilic His112. To structurally investigate the mechanism of hHint1 catalysis, we have designed and prepared nucleoside thiophosphoramidate substrates that are able to capture the transiently formed nucleotidylated-His112 intermediate (E*) using time-dependent crystallography. Utilizing a catalytically inactive hHint1 His112Asn enzyme variant and wild-type enzyme, the enzyme-substrate (ES) and product (EP) complexes were also cocrystallized, respectively, thus providing a structural map of the reaction trajectory. On the basis of these observations and the mechanistic necessity of proton transfers, proton inventory studies were carried out. Although we cannot completely exclude the possibility of more than one proton in flight, the results of these studies were consistent with the transfer of a single proton during the formation of the intermediate. Interestingly, structural analysis revealed that the critical proton transfers required for intermediate formation and hydrolysis may be mediated by a conserved active site water channel. Taken together, our results provide mechanistic insights underpinning histidine nucleophilic catalysis in general and hHint1 catalysis, in particular, thus aiding the design of future proTides and the elucidation of the natural function of the Hint family of enzymes.
人类组氨酸三联体核苷酸结合蛋白1(hHint1)被归类为一种高效的核苷磷酰胺酶和酰基-腺苷单磷酸水解酶。已证明人类Hint1对于核苷酸抗病毒前体药物(即前体药物)的代谢活化至关重要,例如美国食品药品监督管理局批准的丙型肝炎药物索磷布韦。hHint1的活性位点由一组严格保守的组氨酸组成,包括亲核性的His112。为了从结构上研究hHint1的催化机制,我们设计并制备了硫代磷酰胺核苷底物,能够利用时间分辨晶体学捕获瞬时形成的核苷酸化-His112中间体(E*)。利用催化无活性的hHint1 His112Asn酶变体和野生型酶,还分别使酶-底物(ES)和产物(EP)复合物共结晶,从而提供了反应轨迹的结构图。基于这些观察结果以及质子转移的机制必要性,进行了质子库存研究。尽管我们不能完全排除有多个质子在转移的可能性,但这些研究结果与中间体形成过程中单个质子的转移是一致的。有趣的是,结构分析表明,中间体形成和水解所需的关键质子转移可能由一个保守的活性位点水通道介导。综上所述,我们的结果为一般的组氨酸亲核催化,特别是hHint1催化提供了机制上的见解,从而有助于未来前体药物的设计以及阐明Hint家族酶的天然功能。